• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec17
Biomea Fusion Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
12:51
Dec15
Biomea Fusion executive purchases 30,000 shares of company stock
00:00
Dec14
Biomea Fusion to participate in the BIO International Convention 2026
15:42
Biomea Fusion's Food Effect Study (COVALENT-121) is expected to be completed by the end of December 2025.
13:31
Biomea Fusion expects to announce initial clinical data for its next-generation oral GLP-1 receptor agonist, BMF-650, in the first half of 2026.
13:31
D. Boral Capital maintains a Buy rating on Biomea Fusion but lowers the price target to $12 from $16.
10:39

Schedules & Filings

Schedules
Filings
Nov4
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -16.41 M, EPS -0.2741

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -20.74 M, EPS -0.5104

May5
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -29.26 M, EPS -0.7989

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More